Buscar resultados de ensayos clínicos
Adenocarcinoma, Clear Cell - 82 Studies Found
Estado | Estudiar |
Active, not recruiting |
Nombre del estudio: Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer Condición:
|
Withdrawn |
Nombre del estudio: Endometriosis and Frequency of Endometriosis-associated Ovarian Carcinomas (EAOC) Condición:
|
Completed |
Nombre del estudio: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer Condición:
|
Completed |
Nombre del estudio: Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer Condición:
|
Completed |
Nombre del estudio: Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer Condición:
|
Recruiting |
Nombre del estudio: Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol Condición:
|
Not yet recruiting |
Nombre del estudio: Study to Evaluate Efficacy and Safety of Sunitinib in Patients With Renal Cell Carcinoma Who Have Progressed to First-line Immunotherapy Treatment Condición: Clear Cell Renal Carcinoma Fecha: 2017-02-23 Intervenciones: Drug: Sunitinib Sunitinib 50 mg/d |
Completed |
Nombre del estudio: Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer Condición:
|